MBX Biosciences (MBX) Property, Plant & Equipment (Net) (2023 - 2026)

MBX Biosciences (MBX) Property, Plant & Equipment (Net) (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	66,921.77 Bn	66,921.49 Bn	-	642,333.36
2	Nanobiotix	1,924.26 Bn	1,924.20 Bn	-	5.32 Mn
3	Akari Therapeutics	975.59 Bn	975.59 Bn	-	-
4	BeOne Medicines	471.47 Bn	466.67 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	121.76 Bn	114.52 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	69.90 Bn	61.15 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.83 Bn	62.83 Bn	-	-
8	Argenx Se	55.77 Bn	50.59 Bn	1.41 Bn	1.96 Bn
9	Revolution Medicines	37.45 Bn	37.45 Bn	-	31.48 Mn
10	MBX Biosciences	2.86 Bn	2.86 Bn	-	3.13 Mn

Download Data